This trial will test whether the dietary supplement nicotinamide riboside (NR) can improve heart function in heart failure patients by increasing levels of the metabolite nicotinamide adenine dinucleotide (NAD+).
1 Primary · 7 Secondary · Reporting Duration: Up to 14 days
Experimental Treatment
Non-Treatment Group
40 Total Participants · 2 Treatment Groups
Primary Treatment: Nicotinamide riboside · Has Placebo Group · Phase < 1
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: